BioCorRx (BICX) Net Margin (2011 - 2026)
BioCorRx (BICX) recorded Net Margin of -387.45% in Q1 2026, up 236.28 percentage points from -623.73% a year earlier.
Powered by 
Analysis
BioCorRx (BICX) Net Margin (2011 - 2026) Analysis & Trends
On a TTM basis, BioCorRx's Net Margin came in at -391.15% as of Mar 31, 2026, up 2999.24 percentage points year-over-year; for FY2025, it was -431.50%, up 66184.59 percentage points from FY2024.
- Annual Net Margin has a five-year change of +2428.13 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -66616.10% in FY2024 (-62391.21 pp), -4224.89% in FY2023 (-2178.12 pp), -2046.77% in FY2022 (+8747.56 pp) and -10794.33% in FY2021 (-7934.70 pp).
- Quarterly Net Margin has ranged from -34165.08% in Q1 2024 to -301.92% in Q3 2025 over the past five years.
- On a year-over-year basis, Net Margin rose in three of the last four quarters, with an average year-over-year change of +9447.30 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 33541.35 percentage points in Q1 2025, against a drop of 31666.23 percentage points in Q1 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.82 Bn | 1,105.41 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 617.41 Bn | 535.94 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 501.29 Bn | 474.40 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 297.07 Bn | 261.06 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 236.34 Bn | 191.74 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.00 Bn | 165.20 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | -1.65% |
| 10 | BioCorRx | 4.32 Mn | 3.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -387.45% |
| Sep 30, 2025 | -301.92% |
| Jun 30, 2025 | -692.01% |
| Mar 31, 2025 | -623.73% |
| Jun 30, 2024 | -30,095.08% |
| Mar 31, 2024 | -34,165.08% |
| Dec 31, 2023 | -5,116.74% |
| Sep 30, 2023 | -8,549.51% |
| Jun 30, 2023 | -4,703.58% |
| Mar 31, 2023 | -2,498.85% |
| Dec 31, 2022 | -1,403.25% |
| Sep 30, 2022 | -1,006.98% |
| Jun 30, 2022 | -8,235.34% |
| Mar 31, 2022 | -4,605.67% |
| Jun 30, 2020 | -2,191.66% |
| Mar 31, 2020 | -2,922.31% |
| Dec 31, 2019 | -1,926.49% |
| Sep 30, 2019 | -2,220.38% |
| Jun 30, 2019 | -3,093.49% |
| Mar 31, 2019 | -2,712.38% |
API Access
BioCorRx Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();